2296
M. Oba et al. / Tetrahedron 66 (2010) 2293–2296
The structure of 2 is well matched with that of 1 except for the
(0.5 mmol scale). 137 mg, 39% yield; colorless crystals; mp 175–
24
N-terminal
Figure 5.
D-Pro residue, as shown by their superimposition in
177 ꢁC (recryst from EtOH); [
a
]
D
ꢀ20.1 (c1.1, CHCl3). IR (in CDCl3
solution) 3327, 1740, 1666 cmꢀ1
;
1H NMR (400 MHz, CDCl3)
d 7.45
(br s, 1H), 7.29–7.39 (m, 5H), 7.25 (br s, 1H), 7.24 (br s, 1H), 7.09 (br s,
1H), 5.19 (d, J¼13.0 Hz,1H), 4.99 (d, J¼13.0 Hz,1H), 4.46 (t, J¼6.7 Hz,
1H), 4.41 (t, J¼6.2 Hz, 1H), 3.97 (m, 1H), 3.68 (s, 3H), 3.55–3.64 (m,
3H), 1.91–2.27 (m, 8H), 1.52 (s, 3H), 1.50 (s, 6H), 1.48 (s, 3H), 1.44 (s,
3H), 1.43 (s, 3H), 1.41 (s, 3H), 1.40 (s, 3H); 13C NMR (100 MHz, CDCl3)
3. Conclusion
Two diastereomeric diproline (L-Pro-L-Pro and D-Pro-L-Pro)
segments were attached on the N-terminus of H-(Aib)4-OMe seg-
ment. X-ray crystallographic analysis revealed the preferred con-
formations of hexapeptides 1 and 2 in the crystalline state. In the
d
175.5,174.6,173.4,172.7,171.4,155.1,135.9,128.6,128.2,127.3, 67.2,
61.5, 58.2, 56.8, 56.6, 56.5, 55.6, 51.9, 47.5, 47.0, 29.7, 29.2, 28.4, 26.3,
25.8, 25.7, 25.2, 25.0, 24.9, 24.5, 24.4, 24.3, 24.0, 19.3; FAB(þ)-MS:
701 (MþH).
crystal state of 1, the homochiral L L
-Pro1- -Pro2 segment adopted
a polyproline type II structure, which induced a left-handed (M)
310-helical structure in the following -(Aib)4- sequence. On the
other hand, in the crystal state of 2, the heterochiral
segment did not form a type-II0
-turn conformation because of the
presence of a fixed water molecule. Thus, the
-Pro2-Aib3 segment
bestowed a left-handed (M) screw sense3c on the following Aib
sequence. That is to say, the two diastereomeric Cbz-Pro- -Pro-
(Aib)4-OMe peptides formed similar structures with different
N-terminal Pro residues. These results will be valuable for re-
searchers investigating the control of secondary structures and may
be also relevant for the de novo design of peptides/proteins.
D L
-Pro1- -Pro2
Acknowledgements
b
L
This work was supported in part by a Grant-in-Aid for Young
Scientists (B) (21790018) and by a Grant-in-Aid for Scientific Re-
search on Priority Areas (No. 20037054, ‘Chemistry of Concerto
Catalysis’) from the Ministry of Education, Science, Sports, and
Culture of Japan.
L
References and notes
4. Experimental
1. (a) Schneider, J. P.; Kelly, J. W. Chem. Rev. 1995, 95, 2169–2187; (b) Venkatraman,
J.; Shankaramma, S. C.; Balaram, P. Chem. Rev. 2001, 101, 3131–3152.
2. (a) Oba, M.; Tanaka, M.; Kurihara, M.; Suemune, H. Helv. Chim. Acta 2002, 85,
3197–3218; (b) Tanaka, M.; Nishimura, S.; Oba, M.; Demizu, Y.; Kurihara, M.;
Doi, M.; Suemune, H. Chem.dEur. J. 2003, 9, 3082–3090; (c) Tanaka, M.;
Demizu, Y.; Doi, M.; Kurihara, M.; Suemune, H. Angew. Chem., Int. Ed. 2004, 43,
5360–5363; (d) Tanaka, M.; Anan, K.; Demizu, Y.; Kurihara, M.; Doi, M.; Sue-
mune, H. J. Am. Chem. Soc. 2005, 127, 11570–11571; (e) Tanaka, M. Chem. Pharm.
Bull. 2007, 55, 349–358; (f) Demizu, Y.; Tanaka, M.; Nagano, M.; Kurihara, M.;
Doi, M.; Maruyama, T.; Suemune, H. Chem. Pharm. Bull. 2007, 55, 840–842; (g)
Nagano, M.; Tanaka, M.; Doi, M.; Demizu, Y.; Kurihara, M.; Suemune, H. Org.
Lett. 2009, 11, 1135–1137.
3. (a) Chou, P. Y.; Fasman, G. D. J. Mol. Biol. 1977, 115 435–175; (b) Wilmot, C. M.;
Thornton, J. M. J. Mol. Biol. 1988, 203, 221–232; (c) Inai, Y.; Oshikawa, T.;
Yamashita, M.; Hirabayashi, T.; Ashitaka, S. J. Chem. Soc. Perkin 2 2001, 892–897.
4. (a) Kemp, D. S.; Curran, T. P.; Boyd, J. G.; Allen, T. J. J. Org. Chem. 1991, 56, 6683–
6697; (b) Kemp, D. S.; Boyd, J. G.; Muendel, C. C. Nature 1991, 352, 451–454; (c)
Rai, R.; Aravinda, S.; Kanagarajadurai, K.; Raghothamana, S.; Shamala, N.;
Balaram, P. J. Am. Chem. Soc. 2006, 128, 7916–7928; (d) Chatterjee, B.; Saha, I.;
Raghothama, S.; Aravinda, S.; Rai, R.; Shamala, N.; Balaram, P. Chem.dEur. J.
2008, 14, 6192–6204.
5. (a) Robinson, J. A. Synlett 2000, 429–441; (b) Hanessian, S.; Angiolini, M.
Chem.dEur. J. 2002, 8, 111–117; (c) Haines, L. A.; Rajagopal, K.; Ozbas, B.; Salick,
D. A.; Pochan, D. J.; Schneider, J. P. J. Am. Chem. Soc. 2005, 127, 17025–17029; (d)
Rai, R.; Raghothama, S.; Balaram, P. J. Am. Chem. Soc. 2006, 128, 2675–2681.
6. (a) Karle, I. L.; Balaram, P. Biochemistry 1990, 29, 6747–6756; (b) Heimgartner, H.
Angew. Chem., Int. Ed. Engl. 1991, 30, 238–264; (c) Wysong, C. L.; Yokum, T. S.;
McLaughlin, M. L.; Hammer, R. P. Chemtech 1997, 27, 26–33; (d) Toniolo, C.;
Crisma, M.; Formaggio, F.; Peggion, C.; Broxterman, Q.; Kaptein, B. J. Incl. Phenom.
Macro. Chem. 2005, 51, 121–136.
7. Sheldrick, G. M. SHELXL 97. Program for Crystal Structure Refinement; University
of Go¨ttingen: Go¨ttingen, 1997.
8. Altomare, A.; Burla, M. C.; Camalli, M.; Cascarano, G. L.; Giacovazzo, C.; Gua-
gliardi, A.; Moliterni, A. G. G.; Polidori, G.; Spagna, R. J. Appl. Crystallogr. 1999,
32, 115–119.
9. Beurskens, P. T.; Admiraal, G.; Beurskens, G.; Bosman, W. P.; de Gelder, R.; Israel,
R.; Smits, J. M. M. The DIRDIF-99 Program System, Technical Report of the Crys-
tallography Laboratory; University of Nijmegen: The Netherlands, 1994.
10. CCDC-757487 and -757488 contain the supplementary crystallographic data for
Union Road, Cambridge CB2 1EZ, UK; fax: þ44 1223 336 033; or deposit@ccdc.
4.1. General methods
Optical rotations [a] were measured with a Jasco DIP-316 po-
D
larimeter using a 0.5 or 1.0 dm cell. 1H NMR and 13C spectra were
recorded on a Varian AS 400 spectrometer, and measurements were
carried out in CDCl3 with tetramethylsilane used as an internal
standard. FTIR spectra were recorded on a JASCO FT/IR-4100 spec-
trometer at 1 cmꢀ1 resolution, with a mean of 32 scans used for the
solution (CDCl3) method and a 0.1 mm path length adopted for
NaCl cells. FABMS spectra were measured on a JEOL JMS-SX 102
spectrometer. Elemental analysis was performed at the Analytical
Center of the Faculty of Sciences at Kyushu University.
4.1.1. Cbz-L-Pro-L-Pro-(Aib)4-OMe (1). A mixture of Cbz-L-Pro-L-Pro-
OH (173 mg, 0.5 mmol), H-(Aib)4-OMe (186 mg, 0.5 mmol),12 EDC
(115 mg, 0.6 mmol), and HOBt (81 mg, 0.6 mmol) in MeCN was
stirred at room temperature for 48 h. The solution was then evapo-
rated; diluted with AcOEt (30 mL); washed with 3% aqueous HCl, 5%
NaHCO3, and brine; and dried over anhydrous MgSO4. Evaporation of
the solvent gave a white solid, which was purified by column chro-
matography on silica gel (n-hexane/AcOEt¼1:9) to give 1 (164 mg,
47%) as colorless crystals. Mp 193–194 ꢁC (recryst from MeOH/H2O);
24
[a]
ꢀ51.2 (c1.7, CHCl3); IR (in CDCl3 solution) 3317, 1741, 1698,
D
1645 cmꢀ1; 1H NMR (400 MHz, CDCl3)
d 7.41 (br s,1H), 7.30–7.36 (m,
5H), 7.21 (br s, 1H), 7.19 (br s, 1H), 6.76 (br s, 1H), 5.14 (ABX,
JAX¼13.0 Hz, JBX¼13.0 Hz, JAB¼37.0 Hz, 2H), 4.50 (t, J¼7.5 Hz, 1H),
4.25 (t, J¼7.5 Hz, 1H), 3.62–3.73 (m, 2H), 3.68 (s, 3H), 3.44 (m, 1H),
3.34 (m, 1H), 2.19–2.37 (m, 2H), 1.79–2.04 (m, 6H), 1.44–1.52 (m,
24H); 13C NMR (100 MHz, CDCl3)
d 175.5, 174.6, 174.2, 173.6, 172.0,
171.3,154.9,136.4,128.5,128.2,128.0, 67.2, 61.8, 59.8, 56.9, 56.8, 56.5,
55.7, 52.0, 47.2, 46.7, 29.0, 28.8, 25.8, 25.6, 25.5, 25.2, 25.0, 24.9, 24.7,
24.5, 23.9; FAB(þ)-MS: 701 (MþH); Anal. Calcd for C35H52N6O9: C,
59.98; H, 7.48; N, 11.99. Found: C, 59.73; H, 7.40; N, 11.91.
11. Ideal backbone torsion angles of type-II0
b
-turn:
f
¼60ꢁ,
4
¼ꢀ120ꢁ. (a) Nair, C.
M.; Vijayan, M.; Venkatachalapathi, Y. V.; Balaram, P. J. Chem. Soc., Chem.
Commun. 1979, 1183–1184; (b) Nair, C. M.; Vijayan, M. J. Chem. Soc. Perkin 2 1980,
1800–1804; (c) Bean, J. W.; Kopple, K. D.; Peishoff, C. E. J. Am. Chem. Soc. 1992,
114, 5328–5334.
4.1.2. Cbz-D-Pro-L-Pro-(Aib)4-OMe (2). Peptide 2 was prepared us-
ing a similar method to that described for the preparation of 1
12. Karle, I. L.; Ranganathan, D.; Lakshmi, C. Biopolymers 2001, 59, 301–304.